Allergic contact dermatitis from a topical corticosteroid mimicking acute generalized exanthematous pustulosis by Broesby-Olsen, Sigurd et al.
LETTERS TO THE EDITOR
Allergic Contact Dermatitis from a Topical Corticosteroid Mimicking Acute Generalized
Exanthematous Pustulosis
Sigurd Broesby-Olsen1, Ole Clemmensen2 and Klaus Ejner Andersen1
Departments of 1Dermatology and 2Pathology, Odense University Hospital, University of Southern Denmark, Sdr. Boulevard 29,
DK-5000 Odense C, Denmark. E-mail: sigurd.broesby.olsen@ouh.fyns-amt.dk
Accepted November 15, 2004.
Sir,
Acute generalized exanthematous pustulosis (AGEP)
designates an uncommon, cutaneous reaction character-
ized by an acute eruption of numerous, small, mostly
non-follicular sterile pustules arising on a widespread
oedematous erythema; fever above 38 C˚; blood neutro-
phil count above 76109/l and spontaneous resolution of
pustules within 15 days. Typical histopathological
findings are subcorneal and/or intra-epidermal pustules,
dermal oedema and perivascular infiltrates of neutro-
phils and eosinophils. Vasculitis and focal necrosis of
keratinocytes may be present. AGEP is mostly a
systemic drug reaction, often due to antibiotics. Other
possible aetiological factors include infections and
mercury (1–4). We present here a case of an AGEP-
like skin eruption as a manifestation of allergic contact
dermatitis to hydrocortisone-17-butyrate. To our
knowledge, this has never been reported before.
CASE REPORT
A 62-year-old retired postman presented with a pruritic rash.
He was previously healthy and had no history of skin disease.
Two weeks before presentation he developed redness, slight
swelling and itch on his right foot and was treated by his
general practitioner with dicloxacillin for erysipelas. The
symptoms progressed and he developed a pustular rash
affecting his thighs, arms and hands accompanied by
an intense, burning itch. After spreading of the cutaneous
eruption dicloxacillin was substituted by erythromycin and
subsequently by ofloxacin, with no effect on the rash, which
progressed until referral.
At the first visit the patient did not disclose the use of topical
remedies except for a moisturizer he had used for several years.
There were no general symptoms of fever, malaise or arthralgia.
Physical examination showed widespread numerous symme-
trically distributed non-follicular pustules on an erythematous
base, primarily on his forearms and antecubital fossae (Fig. 1). In
addition there was a crusted dermatitis affecting his right foot,
thighs and both hands. There was no mucosal involvement.
Blood samples showed an elevated blood neutrophil count
(7.76109/l), but a normal total white cell count and no
eosinophilia. Other blood samples were unremarkable including
haemoglobin, blood platelets, ESR, C-reactive protein, alanine
transaminase, alkaline phophatase, albumin, creatinine and urea.
No bacteria or fungi were cultured from the pustules.
A 4-mm punch biopsy from the forearm showed multifocal
subcorneal pustules or superficial intra-epidermal pustules
with no follicular continuity. A few eosinophils were scattered
among the neutrophils of the pustules. There was a slight
spongiosis, but no remarkable spongioform pustulation. There
was a moderate subepidermal oedema and a heavy diffuse
mixed inflammatory cell infiltrate of neutrophils, eosinophils
and lymphocytes. There was no vasculitis (Fig. 2).
At his first visit an AGEP reaction to penicillin was suspected.
Ofloxacin was discontinued. He was treated with potent topical
steroid (betamethason-17-valerate), oral prednisolone 25 mg/day
and potassium permanganate soaks. Four days later the skin had
recovered almost completely. Four weeks later after withdrawal
of systemic treatment, the patient underwent an allergological
investigation including patch testing with the European standard
Fig. 1. Numerous small, non-follicular, sterile pustules on a wide-
spread oedematous erythema on the forearm.
Fig. 2. A biopsy showing intracorneal pustules dominated by
neutrophils with a slight adjacent spongiosis. There is oedema and a
mixed inflammatory cell infiltrate in the superficial dermis.
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series (TRUEH test, panels 1 and 2), supplemented with
petrolatum-based preparations, a corticosteroid series and
cosmetics used (Finn chambers on Scanpor). The reactions were
read at day 3 and day 7.
A positive reaction to nickel sulphate and potassium
dichromate was of no current clinical relevance. In addition,
a strong (++) reaction to budenoside 0.01% pet. and a +
reaction to hydrocortisone-17-butyrate 0.1% pet. was seen at
day 3. Pustules were not observed when reading the positive
patch test to steroids, and a biopsy from the positive patch test
showed changes compatible with contact dermatitis and no
pustules. A closer history revealed that, in addition to the oral
antibiotics, the patient had used a topical corticosteroid
containing hydrocortisone-17-butyrate from the early onset
of the skin symptoms. An intradermal test and oral provoca-
tion with penicillin was negative. Further, patch testing with
erythromycin, ciprofloxacin and dicloxacillin was negative. It
was concluded that the patient had a strong corticosteroid
allergy and that his AGEP-like eruption was a manifestation
of allergic contact dermatitis.
DISCUSSION
The presentation of allergic contact dermatitis mimick-
ing AGEP is remarkable and, to the best of our
knowledge, has not been reported before. The diagnosis
of AGEP in this case was suspected on the basis of
clinical and histopathological morphology of his cuta-
neous rash that was convincingly suggestive of this
diagnosis. Furthermore he fulfils suggested criteria of
AGEP (2, 4), except that he had no fever.
The various histological differential diagnoses of
subcorneal pustulation comprise pustular psoriasis,
subcorneal pustulation of Sneddon-Wilkinson, IgA
pemphigus, subcorneal-type and odd types of dermato-
phytosis, which were all excluded clinically and histo-
pathologically (direct IF showed no deposits of
immunoglobulin, and fungi were not demonstrated).
The negative intradermal test and peroral challenge
with penicillin exclude the suspected penicillin as the
cause of the pustular rash. Since erythromycin and
ofloxacin, which have both been reported among the
inducers of AGEP (4), were administered after the
dissemination of the pustular rash, it seems fair to rule
out these drugs as having any pathogenic importance.
Patch testing for the suspected drugs has been shown to
be of good value when evaluating patients with AGEP
(5, 6). A provocation of AGEP has even been reported
from patch testing with the offending drug (7). In
this case patch tests with the antibiotics used were
negative.
A manifestation of allergic contact dermatitis result-
ing from the use of a topical drug containing hydro-
cortisone-17-butyrate must be the only plausible
explanation of the eruption in our patient.
Allergic contact dermatitis to corticosteroids, first
described in 1959 (8) is an uncommon side effect of
dermatological therapy (9). Concomitant reactivity to
budesonide and hydrocortisone-17-butyrate is the rule
(10). Typically, allergy to a topical steroid should be
suspected in patients with long-standing eczematous
skin diseases who do not improve or deteriorate during
treatment with a topical corticosteroid, but it can also
result in acute eczema (11). To the best of our
knowledge a pustular eruption as a result of allergy to
a topical corticosteroid has not been reported before.
Pustular patch test reactions are not uncommon; they
may be elicited by metal salts and are usually regarded
as irritant reactions (12).
In conclusion, an AGEP-like eruption as a manifesta-
tion of allergic contact dermatitis from topical cortico-
steroids is a rare type of allergic contact dermatitis, not
hitherto reported. The varied spectrum of agents inducing
AGEP may indicate that this pustular reaction pattern can
be caused by different mechanisms and not just be of an
allergic nature, like the reaction patterns of erythema
multiforme and toxic epidermal necrolysis.
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